- Home
- AUTL vs ACIC Comparison
AUTL vs ACIC Comparison
Compare AUTL & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- ACIC
- Stock Information
- Founded
- AUTL 2014
- ACIC 1999
- Country
- AUTL United Kingdom
- ACIC United States
- Employees
- AUTL N/A
- ACIC N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- ACIC Property-Casualty Insurers
- Sector
- AUTL Health Care
- ACIC Finance
- Exchange
- AUTL Nasdaq
- ACIC Nasdaq
- Market Cap
- AUTL 625.4M
- ACIC 556.0M
- IPO Year
- AUTL 2018
- ACIC N/A
- Fundamental
- Price
- AUTL $1.32
- ACIC $10.90
- Analyst Decision
- AUTL Strong Buy
- ACIC Buy
- Analyst Count
- AUTL 5
- ACIC 1
- Target Price
- AUTL $9.12
- ACIC $16.00
- AVG Volume (30 Days)
- AUTL 4.2M
- ACIC 172.0K
- Earning Date
- AUTL 11-11-2025
- ACIC 11-05-2025
- Dividend Yield
- AUTL N/A
- ACIC 4.60%
- EPS Growth
- AUTL N/A
- ACIC 14.01
- EPS
- AUTL N/A
- ACIC 1.63
- Revenue
- AUTL $29,934,000.00
- ACIC $320,072,000.00
- Revenue This Year
- AUTL $641.63
- ACIC $4.91
- Revenue Next Year
- AUTL $109.21
- ACIC $4.16
- P/E Ratio
- AUTL N/A
- ACIC $6.66
- Revenue Growth
- AUTL 185.17
- ACIC 33.90
- 52 Week Low
- AUTL $1.11
- ACIC $8.82
- 52 Week High
- AUTL $5.00
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- AUTL 26.05
- ACIC 49.26
- Support Level
- AUTL $1.30
- ACIC $10.31
- Resistance Level
- AUTL $1.46
- ACIC $11.17
- Average True Range (ATR)
- AUTL 0.09
- ACIC 0.35
- MACD
- AUTL 0.01
- ACIC -0.03
- Stochastic Oscillator
- AUTL 7.25
- ACIC 34.75
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.